Both in Pharmaceuticals
Cytokinetics vs Alkermes
Over the past year CYTK returned −0.9% and ALKS returned +47.7%; their daily moves had a correlation of 0.32.
CYTK −0.9% ALKS +47.7%Growth of $1, one year, split-adjusted
| Metric | CYTK | ALKS |
|---|---|---|
| Price | $62.99 | $45.34 |
| Market cap | $8.76B | $7.61B |
| Today | −0.51% | −0.07% |
| 1 month | −4.0% | +11.8% |
| 6 months | −0.6% | +35.8% |
| Year to date | −0.9% | +62.0% |
| 1 year | +1.6% | +44.2% |
| Revenue growth (YoY) | −57.1% | +27.0% |
| Gross margin | 90.5% | 80.2% |
| Net margin | −694.4% | 0.1% |
| P/E (TTM) | — | 115.0× |
| Price / sales | 129.4× | 4.6× |
| Net cash | $18.6M | -$846.5M |
| Dividend yield | — | — |
| Volatility (60d) | 33.6% | 31.7% |
| Short % of float | 15.4% | 11.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).